|Karolinska Development AB -- Sweden Stock|| |
SEK 5.44 0.1 1.81%
Vice President IPR
Ms. AnnSofie Sternas was Vice President IPR at Karolinska Development AB since June 2012. She is European Patent Attorney and holds MS in Chemical Engineering. AnnSofie Sternas has almost 20 years of IP experience from large pharmaceutical companies and has held senior IPR positions within Astra and AstraZeneca. During many years AnnSofie was heavily involved in IP litigation of several blockbuster drugs. AnnSofie is specialized in IPstrategic matters with a heavy focus on the US legislation particularly IP in the interface between patent law and regulatory law. She is also part of a number of management teams within the Karolinska Development portfolio companies.
Age: 53 President Since 2012
46 8 52 48 60 70 http://www.karolinskadevelopment.com
The company has return on total asset (ROA)
of (3.53) %
which means that it has lost $3.53 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of 86.56 %
meaning that it generated $86.56 on every $100 dollars invested by stockholders.
The company has accumulated 368.41 M in total debt with debt to equity ratio (D/E) of 156.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Karolinska Development AB has Current Ratio of 15.89 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Karolinska Development AB is a VC firm specializing in investments in growth capital, seed stage, and early stage companies. Karolinska Development AB (KDEV) is traded on Stockholm Stock Exchange in Sweden. It is located in Solna, and employs 13 people.